Skip To Main Content
Jorge Barriuso on Muck Rack

Jorge Barriuso

As seen in: Nature, Wiley Online Library, ESMO Daily Reporter, Cancer Treatment Reviews, EJSO - European Journal of Surgical Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jorge

Contact Jorge, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Evaluating the need for performing a right hemicolectomy in appendiceal adenocarcinomas.

|
By Lorena Martín-Román, Lucy Larby, Madeleine Strach, Chris O´Brien Lifehouse, Bipasha Chakrabarty, Jorge Barriuso, Omer Aziz, Sarah T. O´Dwyer
| EJSO - European Journal of Surgical Oncology Verified
Keywords Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy right hemicolectomy appendiceal mucinous adenocarcinoma non-mucinous appendiceal adenocarcinoma lymph node status Get full text access Log in, subscribe or purchase for full access. REFERENCES 1. Shaib, W.L. ∙ Goodman, M. ∙ Chen, Z. ... Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis Am J Clin Oncol. 2017 Dec; 40(6):569-573 3. Carr, N.J. ∙ Cecil, T.D. ∙ Mohamed, F. ...
Open in Who Shared Issue with article?

New treatment modalities in gastrointestinal malignancies: broadening the therapeutic horizon

|
By Jorge Barriuso
| ESMO Daily Reporter Verified
Progress in gastrointestinal (GI) cancers, most notably in tumours characterised by microsatellite instability (MSI), has been driven for many years by immune checkpoint inhibitors delivering meaningful benefit in these subgroups (N Engl J Med. 2015;372:2509–2520; Science. 2017;357:409–413). The therapeutic landscape is now entering a new phase, shaped by advances that extend beyond immunotherapy and into targeted and molecularly driven strategies.
Open in Who Shared Issue with article?

ESMO Gastrointestinal Cancers Congress 2026

|
By Elizabeth A. Smyth, Jorge Barriuso
| ESMO Daily Reporter Verified
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used. For more detailed information on the cookies we use, please check our Privacy Policy. Necessary cookies Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
Open in Who Shared Issue with article?
See all 11 articles